Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
Antimicrobial resistance (AMR) is a global threat. As per the UN estimates, the global trends reveal that each year 7,00,000 people die due to drug-resistance. Moreover, around 230,000 people die due to multidrug-resistant tuberculosis. The trends in the US depicted an equally disheartening. A report titled...
Find More
Antibiotics are amazing. Right? There was a time when thousands of people lost their lives due to some severe bacterial diseases. However, thanks to the British scientist Alexander Fleming, now many life-threatening diseases can be cured using Antibiotics when given at the right time. With the success of penicillin...
Find More
AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out to raise up to USD 86 Million through an IPO. The AstraZeneca spinout is attempting to fund a phase 3 trial of a drug to overcome bacterial resistance to beta-lactams. In 2015, ...
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
